BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35806102)

  • 21. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
    Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
    Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
    Msaouel P; Malouf GG; Su X; Yao H; Tripathi DN; Soeung M; Gao J; Rao P; Coarfa C; Creighton CJ; Bertocchio JP; Kunnimalaiyaan S; Multani AS; Blando J; He R; Shapiro DD; Perelli L; Srinivasan S; Carbone F; Pilié PG; Karki M; Seervai RNH; Vokshi BH; Lopez-Terrada D; Cheng EH; Tang X; Lu W; Wistuba II; Thompson TC; Davidson I; Giuliani V; Schlacher K; Carugo A; Heffernan TP; Sharma P; Karam JA; Wood CG; Walker CL; Genovese G; Tannir NM
    Cancer Cell; 2020 May; 37(5):720-734.e13. PubMed ID: 32359397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal medullary carcinomas depend upon
    Hong AL; Tseng YY; Wala JA; Kim WJ; Kynnap BD; Doshi MB; Kugener G; Sandoval GJ; Howard TP; Li J; Yang X; Tillgren M; Ghandi M; Sayeed A; Deasy R; Ward A; McSteen B; Labella KM; Keskula P; Tracy A; Connor C; Clinton CM; Church AJ; Crompton BD; Janeway KA; Van Hare B; Sandak D; Gjoerup O; Bandopadhayay P; Clemons PA; Schreiber SL; Root DE; Gokhale PC; Chi SN; Mullen EA; Roberts CW; Kadoch C; Beroukhim R; Ligon KL; Boehm JS; Hahn WC
    Elife; 2019 Mar; 8():. PubMed ID: 30860482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic challenges of renal medullary carcinoma and the role for cytologic assessment: Case report and literature review.
    Severseike BO; Schafernak KT; Willard SD; Goncalves LF; Kothari AK; Eshun FK; Mangum R
    J Clin Lab Anal; 2023 Apr; 37(4):e24854. PubMed ID: 36843202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.
    Tsuzuki S; Kataoka TR; Ito H; Ueshima C; Asai S; Yokoo H; Haga H
    Pathol Int; 2019 Dec; 69(12):710-714. PubMed ID: 31617267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMARCB1 regulates the hypoxic stress response in sickle cell trait.
    Soeung M; Perelli L; Chen Z; Dondossola E; Ho IL; Carbone F; Zhang L; Khan H; Le CN; Zhu C; Peoples MD; Feng N; Jiang S; Zacharias NM; Minelli R; Shapiro DD; Deem AK; Gao S; Cheng EH; Lucchetti D; Walker CL; Carugo A; Giuliani V; Heffernan TP; Viale A; Tannir NM; Draetta GF; Msaouel P; Genovese G
    Proc Natl Acad Sci U S A; 2023 May; 120(21):e2209639120. PubMed ID: 37186844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
    Yang XJ; Sugimura J; Tretiakova MS; Furge K; Zagaja G; Sokoloff M; Pins M; Bergan R; Grignon DJ; Stadler WM; Vogelzang NJ; Teh BT
    Cancer; 2004 Mar; 100(5):976-85. PubMed ID: 14983493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.
    Darr J; Klochendler A; Isaac S; Geiger T; Eden A
    Mol Cancer; 2015 Sep; 14():167. PubMed ID: 26370283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
    Lai JZ; Lai HH; Cao D
    Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal medullary carcinoma in a white adolescent with sickle cell trait.
    Daher P; Bourgi A; Riachy E; Khoury A; Rehayem C; Sader-Ghorra C
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e285-9. PubMed ID: 24517963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal medullary carcinoma and ABL gene amplification.
    Simpson L; He X; Pins M; Huang X; Campbell SC; Yang XJ; Perlman EJ; Bergan RC
    J Urol; 2005 Jun; 173(6):1883-8. PubMed ID: 15879768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.
    Kuroda N; Karashima T; Inoue K; Kasajima A; Ohe C; Kawakami F; Mikami S; Matsuura K; Moriyama M; Nagashima Y; Petersson F; Lopez JI; Cohen RJ; Michal M; Hes O
    Pol J Pathol; 2015 Mar; 66(1):3-8. PubMed ID: 26017874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
    Bourdeaut F; Chi SN; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.
    Deisch J; Raisanen J; Rakheja D
    Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal medullary carcinoma and its association with sickle cell trait: a case report and literature review.
    Holland P; Merrimen J; Pringle C; Wood LA
    Curr Oncol; 2020 Feb; 27(1):e53-e56. PubMed ID: 32218668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Renal Tumors: Updates in the Molecular Era.
    Treece AL
    Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal medullary carcinoma and sickle cell trait: A systematic review.
    Alvarez O; Rodriguez MM; Jordan L; Sarnaik S
    Pediatr Blood Cancer; 2015 Oct; 62(10):1694-9. PubMed ID: 26053587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
    Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
    Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal Medullary Carcinoma: Establishing Standards in Practice.
    Beckermann KE; Sharma D; Chaturvedi S; Msaouel P; Abboud MR; Allory Y; Bourdeaut F; Calderaro J; de Cubas AA; Derebail VK; Hong AL; Naik RP; Malouf GG; Mullen EA; Reuter VE; Roberts CWM; Walker CL; Wood CG; DeBaun MR; Van Poppel H; Tannir NM; Rathmell WK
    J Oncol Pract; 2017 Jul; 13(7):414-421. PubMed ID: 28697319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.